Skip to main content
. 2022 Sep 20;25(1):156–165. doi: 10.1111/dom.14858

TABLE 1.

Baseline characteristics of the study population (demographics, lifestyle factors, diabetes complications and other comorbidities)

Pre‐matched Matched
SGLT2 inhibitor cohort DPP‐4 inhibitor cohort SMD SGLT2 inhibitor cohort DPP‐4 inhibitor cohort SMD
Number of patients 13 617 29 426 8650 8650
Age at index, mean (SD) years 57.71 (10.64) 65.97 (12.83) 0.701 58.97 (10.65) 58.97 (11.56) 0.000
Age group, n (%)
18‐54 years 5401 (39.66) 6151 (20.90) 3087 (35.69) 3210 (37.11)
55‐64 years 4675 (34.33) 7011 (23.83) 2965 (34.28) 2748 (31.77)
65‐74 years 2964 (21.77) 8511 (28.92) 2103 (24.31) 1969 (22.76)
75+ years 577 (4.24) 7753 (26.35) 495 (5.72) 723 (8.36)
Male, n (%) 7626 (56.00) 16 438 (55.86) 0.003 4942 (57.13) 4945 (57.17) 0.001
Ethnicity, n (%) 0.092 0.028
White 6650 (48.84) 14 220 (48.32) 4208 (48.65) 4140 (47.86)
Black 159 (1.17) 563 (1.91) 117 (1.35) 111 (1.28)
South Asian 521 (3.83) 1481 (5.03) 374 (4.32) 370 (4.28)
Mixed race 92 (0.68) 267 (0.91) 73 (0.84) 65 (0.75)
Other ethnic minorities 42 (0.31) 111 (0.38) 31 (0.36) 41 (0.47)
Missing 6153 (45.19) 12 784 (43.44) 3847 (44.47) 3923 (45.35)
Townsend deprivation quintile, n (%) 0.082 0.009
1 (least deprived) 1827 (13.42) 4484 (15.24) 1196 (13.83) 1206 (13.94)
2 1943 (14.27) 4539 (15.43) 1248 (14.43) 1262 (14.59)
3 2359 (17.32) 5300 (18.01) 1495 (17.28) 1489 (17.21)
4 2381 (17.49) 5066 (17.22) 1465 (16.94) 1451 (16.77)
5 (Most deprived) 1973 (14.49) 3882 (13.19) 1233 (14.25) 1246 (14.40)
Missing 3134 (23.02) 6155 (20.92) 2013 (23.27) 1996 (23.08)
Calendar year at index, n (%) 0.666 0.026
2012 0 (0) 994 (3.38) 0 (0) 0 (0)
2013 491 (3.61) 5703 (19.38) 352 (4.07) 359 (4.15)
2014 1727 (12.68) 5166 (17.56) 975 (11.27) 997 (11.53)
2015 2551 (18.73) 5151 (17.50) 1494 (17.27) 1561 (18.05)
2016 2991 (21.97) 4552 (15.47) 1900 (21.97) 1900 (21.97)
2017 3043 (22.35) 4139 (14.07) 1994 (23.05) 1939 (22.42)
2018 2814 (20.67) 3721 (12.65) 1935 (22.37) 1894 (21.90)
Lifestyle variables, n (%)
Obesity 10 741 (78.88) 16 581 (56.35) 0.496 6304 (72.88) 6329 (73.17) 0.007
Overweight 2661 (19.54) 9670 (32.86) 0.306 2047 (23.66) 2035 (23.53) 0.003
Smoking status 7832 (57.52) 16 031 (54.48) 0.061 4910 (56.76) 4918 (56.86) 0.002
Alcohol abuse 9038 (66.37) 18 235 (61.97) 0.092 5735 (66.30) 5726 (66.20) 0.002
Drug abuse 182 (1.34) 262 (0.89) 0.043 110 (1.27) 116 (1.34) 0.006
Diabetes complications, n (%)
Diabetic retinopathy 7752 (56.93) 16 057 (54.57) 0.048 4363 (50.44) 4462 (51.58) 0.023
Diabetes with other ophthalmic manifestations 325 (2.39) 1367 (4.65) 0.123 217 (2.51) 220 (2.54) 0.002
Retinal detachment, vitreous haemorrhage, vitrectomy 106 (0.78) 306 (1.04) 0.028 61 (0.71) 58 (0.67) 0.004
Retinal laser coagulation therapy 75 (0.55) 119 (0.40) 0.021 23 (0.27) 28 (0.32) 0.011
Diabetic neuropathy 2535 (18.62) 5926 (20.14) 0.039 1369 (15.83) 1404 (16.23) 0.011
Diabetic nephropathy 65 (0.48) 586 (1.99) 0.137 31 (0.36) 33 (0.38) 0.004
Hypoglycaemia 463 (3.40) 1118 (3.80) 0.021 237 (2.74) 241 (2.79) 0.003
Hyperglycaemia 490 (3.60) 1010 (3.43) 0.009 243 (2.81) 238 (2.75) 0.004
Disorders of fluid electrolyte and acid‐base balance 5 (0.04) 56 (0.19) 0.046 4 (0.05) 2 (0.02) 0.012
Diabetic ketoacidosis 30 (0.22) 44 (0.15) 0.016 10 (0.12) 17 (0.20) 0.021
Hyperosmolar hyperglycaemic nonketotic syndrome 5 (0.04) 21 (0.07) 0.015 2 (0.02) 3 (0.03) 0.007
Diabetes with peripheral circulatory disorders 5 (0.04) 64 (0.22) 0.051 4 (0.05) 5 (0.06) 0.005
Diabetic foot 13 203 (96.96) 28 184 (95.78) 0.063 8298 (95.93) 8304 (96.00) 0.004
Gangrene 6 (0.04) 38 (0.13) 0.029 5 (0.06) 2 (0.02) 0.017
Lower extremity amputation 77 (0.57) 233 (0.79) 0.028 50 (0.58) 47 (0.54) 0.005
Osteomyelitis 70 (0.51) 183 (0.62) 0.014 40 (0.46) 42 (0.49) 0.003
Skin infections 508 (3.73) 939 (3.19) 0.030 319 (3.69) 288 (3.33) 0.019
Erectile dysfunction 2154 (15.82) 4245 (14.43) 0.039 1269 (14.67) 1275 (14.74) 0.002
Diabetes with unspecified complication 108 (0.79) 258 (0.88) 0.009 43 (0.50) 49 (0.57) 0.01
Diabetes mellitus without mention of complications 24 (0.18) 35 (0.12) 0.015 13 (0.15) 15 (0.17) 0.006
Other comorbidities, n (%)
Hypertension 7744 (56.87) 18 044 (61.32) 0.091 4772 (55.17) 4783 (55.29) 0.003
Ischaemic heart disease 1757 (12.90) 5548 (18.85) 0.163 1111 (12.84) 1091 (12.61) 0.007
Acute myocardial infarction 763 (5.60) 2242 (7.62) 0.081 489 (5.65) 487 (5.63) 0.001
Stable angina 821 (6.03) 2838 (9.64) 0.135 496 (5.73) 481 (5.56) 0.008
Previous cardiac procedure 476 (3.50) 1444 (4.91) 0.070 300 (3.47) 297 (3.43) 0.002
History of CABG or PTCA 209 (1.53) 890 (3.02) 0.100 137 (1.58) 137 (1.58) 0
Any stroke 350 (2.57) 1492 (5.07) 0.131 249 (2.88) 236 (2.73) 0.009
Haemorrhagic stroke 26 (0.19) 122 (0.41) 0.041 23 (0.27) 19 (0.22) 0.009
Cerebrovascular procedure 2 (0.01) 3 (0.01) 0.004 0 (0) 1 (0.01) 0.015
CHF 313 (2.30) 1546 (5.25) 0.155 213 (2.46) 201 (2.32) 0.009
Peripheral vascular disease or surgery 185 (1.36) 627 (2.13) 0.059 119 (1.38) 108 (1.25) 0.011
Atrial fibrillation 503 (3.69) 2401 (8.16) 0.190 353 (4.08) 352 (4.07) 0.001
Other cardiac dysrhythmia 26 (0.19) 52 (0.18) 0.003 13 (0.15) 18 (0.21) 0.014
Oedema 2135 (15.68) 5739 (19.50) 0.101 1269 (14.67) 1296 (14.98) 0.009
COPD 757 (5.56) 2345 (7.97) 0.096 512 (5.92) 514 (5.94) 0.001
Asthma 2279 (16.74) 4205 (14.29) 0.068 1352 (15.63) 1348 (15.58) 0.001
Pneumonia 740 (5.43) 1814 (6.16) 0.031 455 (5.26) 452 (5.23) 0.002
Chronic kidney disease 550 (4.04) 6099 (20.73) 0.524 404 (4.67) 421 (4.87) 0.009
Chronic renal insufficiency 54 (0.40) 540 (1.84) 0.137 40 (0.46) 42 (0.49) 0.003
Chronic kidney disease stage 1‐2 420 (3.08) 1188 (4.04) 0.051 231 (2.67) 236 (2.73) 0.004
Chronic kidney disease stage 3‐4 166 (1.22) 1855 (6.30) 0.270 127 (1.47) 126 (1.46) 0.001
Hypertensive nephropathy 1 (0.01) 4 (0.01) 0.006 0 (0) 0 (0)
Liver disease 165 (1.21) 343 (1.17) 0.004 104 (1.20) 116 (1.34) 0.012
Osteoarthritis 2416 (17.74) 6918 (23.51) 0.143 1543 (17.84) 1554 (17.97) 0.003
Other arthritis, arthropathies and musculoskeletal pain 201 (1.48) 545 (1.85) 0.029 142 (1.64) 149 (1.72) 0.006
Bone fractures 1510 (11.09) 3391 (11.52) 0.014 933 (10.79) 937 (10.83) 0.001
Falls 321 (2.36) 1270 (4.32) 0.109 219 (2.53) 217 (2.51) 0.001
Osteoporosis 288 (2.12) 1405 (4.77) 0.146 200 (2.31) 197 (2.28) 0.002
Hyperthyroidism 114 (0.84) 281 (0.95) 0.012 62 (0.72) 59 (0.68) 0.004
Hypothyroidism 1372 (10.08) 2988 (10.15) 0.003 800 (9.25) 803 (9.28) 0.001
Other disorders of the thyroid gland 10 (0.07) 17 (0.06) 0.006 5 (0.06) 6 (0.07) 0.005
Depression 5147 (37.80) 8801 (29.91) 0.167 2996 (34.64) 3040 (35.14) 0.011
Anxiety 2239 (16.44) 4492 (15.27) 0.032 1408 (16.28) 1450 (16.76) 0.013
Sleep disorder 926 (6.80) 920 (3.13) 0.170 426 (4.92) 409 (4.73) 0.009
Dementia 85 (0.62) 806 (2.74) 0.165 69 (0.80) 71 (0.82) 0.003
Delirium 10 (0.07) 51 (0.17) 0.028 8 (0.09) 8 (0.09) 0
Psychosis 94 (0.69) 234 (0.80) 0.012 69 (0.80) 76 (0.88) 0.009
Foot ulcer 47 (0.35) 91 (0.31) 0.006 24 (0.28) 26 (0.30) 0.004
Cellulitis or abscess of toe 2 (0.01) 4 (0.01) 0.001 0 (0) 0 (0)
Imaging 4079 (29.96) 8883 (30.19) 0.005 2511 (29.03) 2509 (29.01) 0.001
Glaucoma or cataracts 497 (3.65) 1725 (5.86) 0.104 307 (3.55) 324 (3.75) 0.01

Abbreviations: CABG, coronary artery bypass grafting; CHF, chronic heart failure; COPD, chronic obstructive pulmonary disease; DPP‐4, dipeptidyl peptidase‐4; PTCA, percutaneous transluminal coronary angioplasty; SD, standard deviation; SGLT2, sodium‐glucose cotransporter‐2; SMD, standardized mean difference.